New Approaches To Neuroblastoma Therapy Consortium

This study tested a new oral drug called lorlatinib in children and adults with advanced neuroblastoma that had come back or stopped responding to other treatments. The main goals were to find a safe dose for children and to see how the body processes the drug. Researchers also l…